BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26538396)

  • 1. IL-17A-Producing γδ T Cells Suppress Early Control of Parasite Growth by Monocytes in the Liver.
    Sheel M; Beattie L; Frame TC; de Labastida Rivera F; Faleiro RJ; Bunn PT; Montes de Oca M; Edwards CL; Ng SS; Kumar R; Amante FH; Best SE; McColl SR; Varelias A; Kuns RD; MacDonald KP; Smyth MJ; Haque A; Hill GR; Engwerda CR
    J Immunol; 2015 Dec; 195(12):5707-17. PubMed ID: 26538396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
    Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
    FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
    Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
    Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ly6C
    Terrazas C; Varikuti S; Oghumu S; Steinkamp HM; Ardic N; Kimble J; Nakhasi H; Satoskar AR
    Sci Rep; 2017 Oct; 7(1):14693. PubMed ID: 29089636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
    Moulik S; Karmakar J; Joshi S; Dube A; Mandal C; Chatterjee M
    Parasite Immunol; 2021 Jan; 43(1):e12783. PubMed ID: 32734677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis.
    Mesquita I; Ferreira C; Barbosa AM; Ferreira CM; Moreira D; Carvalho A; Cunha C; Rodrigues F; Dinis-Oliveira RJ; Estaquier J; Castro AG; Torrado E; Silvestre R
    Cytokine; 2018 Dec; 112():16-20. PubMed ID: 30017388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.
    Varikuti S; Natarajan G; Volpedo G; Singh B; Hamza O; Messick GV; Guerau-de-Arellano M; Papenfuss TL; Oghumu S; Satoskar AR
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
    Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis.
    Varikuti S; Verma C; Holcomb E; Jha BK; Viana A; Maryala R; Lamenza F; McElwain BK; Doni NY; Papenfuss T; Oghumu S; Gannavaram S; Nakhasi HL; Satoskar AR
    J Immunol; 2021 Sep; 207(5):1322-1332. PubMed ID: 34341171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
    Engwerda CR; Smelt SC; Kaye PM
    Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Roles for CD4
    Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
    J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 negatively regulates the production of inflammatory cytokines/chemokines and IL-17 in visceral leishmaniasis.
    Saha A; Biswas A; Srivastav S; Mukherjee M; Das PK; Ukil A
    J Immunol; 2014 Sep; 193(5):2330-9. PubMed ID: 25049356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.